| OncoNeth Team |
|
The OncoNeth team consists of specialists in the area of reimbursement, medical and marketing with a minimum of 13 years of industry experience and a strong background in oncology.
Annoesjka Novák holds a University degree in Human Nutrition and a Masters in Clinical Epidemiology. She combines a unique mix of experience from governmental and leading commercial organizations at both a global and local level. Annoesjka has over 17 years experience in global drug development strategy, health economics & outcomes research and pricing & reimbursement. Annoesjka has successfully supported big- and middle pharma companies in the reimbursement and pricing procedures for mainly oncology products. Through her high-level professional network, Annoesjka is ahead of future reimbursement developments in the Netherlands and Europe.
For further information, please view her profile on LinkedIn • http://www.linkedin.com/in/annoesjkanovak
Charles Afram has a Masters degree in Molecular Biology and has over 13 years of experience in the Pharmaceutical Industry. Charles has worked in the sales, marketing, medical and regulatory areas of different Top-10 companies and is highly specialized in oncology and haematology. As the medical manager of different oncology drugs, Charles has extensive experience in the pre-marketing and introduction of oncology drugs in the Netherlands.
For further information, please view his profile on LinkedIn • http://www.linkedin.com/in/afram12
Jan Gerritsen has over 19 years experience in the pharmaceutical industry and Oncology in the Netherlands. Jan brings over 14 years of management experience of Oncology franchises, marketing- and salesteams and of large projects and clinical trials in Oncology to our customers. Since 2004 Jan works as a consultant for Oncology companies, Government, Healthcare insurers and patient advocate groups. Jan has an extensive network of Key Opinion Leaders and cooperative groups in Oncology and the management experience in the (pre)marketing and introduction of different compounds in the Oncologymarket.
For further information, please view his profile on LinkedIn • http://www.linkedin.com/in/jangerritsen |